Clinical Trials Browser

Phase 3 × Completed × osimertinib × Clear all

Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer

Locally Advanced or Metastatic EGFR T790M+ NSCLC